name,category,termsB-cell scaffold protein with ankyrin repeats 1,INTERPRO[450016208$IPR017893:DBB domain]
B-cell scaffold protein with ankyrin repeats 1,OMIM_DISEASE[520001949$Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus, 520002051$Genome-wide association study targeting systemic lupus erythematosus., 520004787$Systemic lupus erythmatosus, association with]
B-cell scaffold protein with ankyrin repeats 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000153$b-cell activation, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001478$systemic lupus erythematosus]
B-cell scaffold protein with ankyrin repeats 1,UP_SEQ_FEATURE[850007064$chain:B-cell scaffold protein with ankyrin repeats, 850103499$domain:DBB, 850112452$region of interest:Interaction with ITPR2, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
G antigen 13,INTERPRO[450007883$IPR008625:GAGE]
G antigen 13,SP_PIR_KEYWORDS[790000356$complete proteome]
G antigen 13,UP_SEQ_FEATURE[850020217$chain:G antigen 13]
G protein-coupled receptor 172B,INTERPRO[450008466$IPR009357:Protein of unknown function DUF1011]
G protein-coupled receptor 172B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001555$transmembrane]
G protein-coupled receptor 172B,UP_SEQ_FEATURE[850039982$chain:Porcine endogenous retrovirus A receptor 2, 850102572$compositionally biased region:Poly-Glu, 850117295$sequence variant, 850117814$signal peptide, 850118623$transmembrane region]
GATS, stromal antigen 3 opposite strand,COG_ONTOLOGY[90000070$Function unknown]
GATS, stromal antigen 3 opposite strand,SP_PIR_KEYWORDS[790000356$complete proteome]
GATS, stromal antigen 3 opposite strand,UP_SEQ_FEATURE[850053875$chain:Putative protein GATS, 850117294$sequence conflict]
LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae),INTERPRO[450001020$IPR001163:Like-Sm ribonucleoprotein, core, 450006064$IPR006649:Like-Sm ribonucleoprotein, eukaryotic and archaea-type, core, 450015452$IPR017132:U6 snRNA-associated Sm-like protein LSm7]
LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae),KEGG_PATHWAY[470038814$hsa03018:RNA degradation, 470038818$hsa03040:Spliceosome]
LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae),PIR_SUPERFAMILY[630028706$PIRSF037188:U6 snRNA-associated Sm-like protein LSm7, 630028707$PIRSF037188:U6_snRNA_Lsm7]
LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae),SMART[760000566$SM00651:Sm]
LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001325$ribonucleoprotein, 790001339$rna-binding]
LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae),UP_SEQ_FEATURE[850067881$chain:U6 snRNA-associated Sm-like protein LSm7]
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa,PIR_SUPERFAMILY[630014996$PIRSF018377:NADH dehydrogenase [ubiquinone] (complex I), beta subcomplex, subunit 2]
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000489$electron transport, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001006$nad, 790001092$oxidoreductase, 790001309$respiratory chain, 790001550$transit peptide, 790001558$transport, 790001589$ubiquinone]
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa,UP_SEQ_FEATURE[850033533$chain:NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial, 850118617$transit peptide:Mitochondrion]
NDRG family member 4,INTERPRO[450003654$IPR004142:Ndr]
NDRG family member 4,PIR_SUPERFAMILY[630019009$PIRSF023830:Caenorhabditis elegans hypothetical protein ZK1073.1]
NDRG family member 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790001162$phosphoprotein]
NDRG family member 4,UP_SEQ_FEATURE[850047002$chain:Protein NDRG4, 850102582$compositionally biased region:Poly-Thr, 850106258$modified residue, 850118574$splice variant]
Ras and Rab interactor-like,INTERPRO[450002747$IPR003123:Vacuolar sorting protein 9]
Ras and Rab interactor-like,SP_PIR_KEYWORDS[790000356$complete proteome, 790000640$GTPase activation, 790001212$polymorphism]
Ras and Rab interactor-like,UP_SEQ_FEATURE[850056672$chain:Ras and Rab interactor-like protein, 850105626$domain:VPS9, 850117295$sequence variant]
SMAD family member 5,BIOCARTA[30000015$h_alkPathway:ALK in cardiac myocytes, 30000074$h_ctcfPathway:CTCF: First Multivalent Nuclear Factor]
SMAD family member 5,INTERPRO[450000993$IPR001132:SMAD domain, Dwarfin-type, 450003179$IPR003619:MAD homology 1, Dwarfin-type, 450011686$IPR013019:MAD homology, MH1, 450012402$IPR013790:Dwarfin, 450016174$IPR017855:SMAD domain-like]
SMAD family member 5,KEGG_PATHWAY[470038850$hsa04350:TGF-beta signaling pathway]
SMAD family member 5,PIR_SUPERFAMILY[630028833$PIRSF037286:Smad protein, 630030713$PIRSF500500:receptor-regulated Smad protein, Smad 1/Smad 5/Smad 8 types]
SMAD family member 5,SMART[760000463$SM00523:DWA, 760000464$SM00524:DWB]
SMAD family member 5,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
SMAD family member 5,UP_SEQ_FEATURE[850032507$chain:Mothers against decapentaplegic homolog 5, 850102577$compositionally biased region:Poly-Lys, 850104765$domain:MH1, 850104766$domain:MH2, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict]
TSC22 domain family, member 3; GRAM domain containing 4,INTERPRO[450000493$IPR000580:TSC-22 / Dip / Bun, 450003692$IPR004182:GRAM]
TSC22 domain family, member 3; GRAM domain containing 4,PIR_SUPERFAMILY[630008527$PIRSF009379:mouse TSC-22 protein]
TSC22 domain family, member 3; GRAM domain containing 4,SMART[760000505$SM00568:GRAM]
TSC22 domain family, member 3; GRAM domain containing 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
TSC22 domain family, member 3; GRAM domain containing 4,UP_SEQ_FEATURE[850022345$chain:GRAM domain-containing protein 4, 850067046$chain:TSC22 domain family protein 3, 850104079$domain:GRAM, 850104712$domain:Leucine-zipper, 850106258$modified residue, 850110939$region of interest:AP1-binding, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
WD repeat domain 62,INTERPRO[450001490$IPR001680:WD40 repeat, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 62,SMART[760000289$SM00320:WD40]
WD repeat domain 62,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 62,UP_SEQ_FEATURE[850100765$chain:WD repeat-containing protein 62, 850106258$modified residue, 850117171$repeat:WD 1, 850117172$repeat:WD 10, 850117173$repeat:WD 11, 850117174$repeat:WD 12, 850117175$repeat:WD 13, 850117176$repeat:WD 14, 850117177$repeat:WD 15, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117200$repeat:WD 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
X-ray repair complementing defective repair in Chinese hamster cells 6; similar to ATP-dependent DNA helicase II, 70 kDa subunit,BIOCARTA[30000289$h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality]
X-ray repair complementing defective repair in Chinese hamster cells 6; similar to ATP-dependent DNA helicase II, 70 kDa subunit,INTERPRO[450002665$IPR003034:DNA-binding SAP, 450004625$IPR005160:Ku70/Ku80 C-terminal arm, 450004626$IPR005161:Ku70/Ku80, N-terminal alpha/beta, 450005596$IPR006164:DNA helicase, ATP-dependent, Ku type, 450005597$IPR006165:DNA helicase, ATP-dependent, Ku70 subunit]
X-ray repair complementing defective repair in Chinese hamster cells 6; similar to ATP-dependent DNA helicase II, 70 kDa subunit,KEGG_PATHWAY[470038826$hsa03450:Non-homologous end-joining]
X-ray repair complementing defective repair in Chinese hamster cells 6; similar to ATP-dependent DNA helicase II, 70 kDa subunit,PIR_SUPERFAMILY[630003123$PIRSF003033:Ku70]
X-ray repair complementing defective repair in Chinese hamster cells 6; similar to ATP-dependent DNA helicase II, 70 kDa subunit,SMART[760000456$SM00513:SAP, 760000498$SM00559:Ku78]
X-ray repair complementing defective repair in Chinese hamster cells 6; similar to ATP-dependent DNA helicase II, 70 kDa subunit,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000138$atp-binding, 790000315$chromosomal protein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000449$DNA binding, 790000452$DNA damage, 790000458$dna recombination, 790000459$dna repair, 790000466$dna-binding, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001478$systemic lupus erythematosus]
X-ray repair complementing defective repair in Chinese hamster cells 6; similar to ATP-dependent DNA helicase II, 70 kDa subunit,UP_SEQ_FEATURE[850006613$chain:ATP-dependent DNA helicase 2 subunit 1, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102599$compositionally biased region:Ser-rich (potentially targets for phosphorylation), 850104595$domain:Ku, 850105257$domain:SAP, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
activating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,INTERPRO[450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010446$IPR011616:bZIP transcription factor, bZIP-1]
activating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038876$hsa04720:Long-term potentiation, 470038877$hsa04722:Neurotrophin signaling pathway, 470038883$hsa04912:GnRH signaling pathway, 470038905$hsa05215:Prostate cancer]
activating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,PIR_SUPERFAMILY[630016200$PIRSF019614:cyclic AMP-dependent transcription factor, ATF4 type]
activating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,SMART[760000306$SM00338:BRLZ]
activating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000449$DNA binding, 790000466$dna-binding, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation]
activating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,UP_SEQ_FEATURE[850012981$chain:Cyclic AMP-dependent transcription factor ATF-4, 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper, 850105852$helix, 850106258$modified residue, 850112353$region of interest:Interaction with GABBR1, 850117294$sequence conflict, 850117295$sequence variant]
agouti signaling protein, nonagouti homolog (mouse),INTERPRO[450007087$IPR007733:Agouti]
agouti signaling protein, nonagouti homolog (mouse),KEGG_PATHWAY[470038885$hsa04916:Melanogenesis]
agouti signaling protein, nonagouti homolog (mouse),OMIM_DISEASE[520004508$Skin/hair/eye pigmentation 9, dark/light hair, 520004943$Two newly identified genetic determinants of pigmentation in Europeans]
agouti signaling protein, nonagouti homolog (mouse),PIR_SUPERFAMILY[630015196$PIRSF018587:agouti-signaling protein/agouti-related protein, 630030928$PIRSF500769:agouti-signaling protein]
agouti signaling protein, nonagouti homolog (mouse),SMART[760000695$SM00792:Agouti]
agouti signaling protein, nonagouti homolog (mouse),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000829$Knottin, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
agouti signaling protein, nonagouti homolog (mouse),UP_SEQ_FEATURE[850004192$chain:Agouti-signaling protein, 850102434$compositionally biased region:Arg/Lys-rich (basic), 850102883$disulfide bond, 850103029$domain:Agouti, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118575$strand]
alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae),INTERPRO[450000283$IPR000330:SNF2-related, 450000580$IPR000679:Zinc finger, GATA-type, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450001628$IPR001841:Zinc finger, RING-type, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding, 450018019$IPR019786:Zinc finger, PHD-type, conserved site]
alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae),OMIM_DISEASE[520000230$Alpha-thalassemia myelodysplasia syndrome, somatic, 520000231$Alpha-thalassemia/mental retardation syndrome, 520001033$Chudley-Lowry syndrome, 520002702$Juberg-Marsidi syndrome, 520003240$Mental retardation-hypotonic facies syndrome, X-linked, 520004519$Smith-Fineman-Myers syndrome, 520004753$Sutherland-Haan syndrome-like]
alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae),SMART[760000158$SM00184:RING, 760000352$SM00401:ZnF_GATA, 760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000446$disease mutation, 790000452$DNA damage, 790000459$dna repair, 790000466$dna-binding, 790000649$helicase, 790000743$hydrolase, 790000930$mental retardation, 790000937$metal-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae),UP_SEQ_FEATURE[850065571$chain:Transcriptional regulator ATRX, 850102568$compositionally biased region:Poly-Asp, 850102570$compositionally biased region:Poly-Gln, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850102581$compositionally biased region:Poly-Ser, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117399$short sequence motif:DEGH box, 850117673$short sequence motif:PxVxL motif, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118825$zinc finger region:GATA-type; atypical, 850118877$zinc finger region:PHD-type]
amyloid beta (A4) precursor protein-binding, family B, member 2,INTERPRO[450001055$IPR001202:WW/Rsp5/WWP, 450005462$IPR006020:Phosphotyrosine interaction region, 450010818$IPR011993:Pleckstrin homology-type]
amyloid beta (A4) precursor protein-binding, family B, member 2,OMIM_DISEASE[520000242$Alzheimer disease, late-onset]
amyloid beta (A4) precursor protein-binding, family B, member 2,SMART[760000401$SM00456:WW, 760000407$SM00462:PTB]
amyloid beta (A4) precursor protein-binding, family B, member 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat]
amyloid beta (A4) precursor protein-binding, family B, member 2,UP_SEQ_FEATURE[850005172$chain:Amyloid beta A4 precursor protein-binding family B member 2, 850104994$domain:PID 1, 850104995$domain:PID 2, 850105731$domain:WW, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
amyloid beta (A4) precursor protein-binding, family B, member 3,INTERPRO[450001055$IPR001202:WW/Rsp5/WWP, 450005462$IPR006020:Phosphotyrosine interaction region, 450010818$IPR011993:Pleckstrin homology-type]
amyloid beta (A4) precursor protein-binding, family B, member 3,SMART[760000401$SM00456:WW, 760000407$SM00462:PTB]
amyloid beta (A4) precursor protein-binding, family B, member 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
amyloid beta (A4) precursor protein-binding, family B, member 3,UP_SEQ_FEATURE[850005173$chain:Amyloid beta A4 precursor protein-binding family B member 3, 850104994$domain:PID 1, 850104995$domain:PID 2, 850105731$domain:WW, 850105852$helix, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
ankyrin repeat and SOCS box-containing 6,INTERPRO[450001330$IPR001496:SOCS protein, C-terminal, 450001870$IPR002110:Ankyrin]
ankyrin repeat and SOCS box-containing 6,SMART[760000220$SM00248:ANK, 760000225$SM00253:SOCS]
ankyrin repeat and SOCS box-containing 6,SP_PIR_KEYWORDS[790000086$ank repeat, 790000356$complete proteome, 790000407$cytoplasm, 790001304$repeat, 790001593$ubl conjugation pathway]
ankyrin repeat and SOCS box-containing 6,UP_SEQ_FEATURE[850005353$chain:Ankyrin repeat and SOCS box protein 6, 850105375$domain:SOCS box, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6]
annexin A11,INTERPRO[450001304$IPR001464:Annexin, 450007488$IPR008157:Annexin, type XI, N-terminal, 450013917$IPR015475:Annexin XI, 450016537$IPR018252:Annexin repeat, conserved site, 450016775$IPR018502:Annexin repeat]
annexin A11,PIR_SUPERFAMILY[630002478$PIRSF002360:annexin VII]
annexin A11,SMART[760000303$SM00335:ANX]
annexin A11,SP_PIR_KEYWORDS[790000012$acetylation, 790000088$annexin, 790000211$calcium, 790000212$calcium binding, 790000216$calcium/phospholipid-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000473$duplication, 790000497$endonexin fold, 790000616$glycoprotein, 790001065$nucleus, 790001155$phospholipid binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
annexin A11,UP_SEQ_FEATURE[850005451$chain:Annexin A11, 850106258$modified residue, 850115661$repeat:Annexin 1, 850115662$repeat:Annexin 2, 850115663$repeat:Annexin 3, 850115664$repeat:Annexin 4, 850117295$sequence variant]
arrestin domain containing 2,INTERPRO[450010005$IPR011021:Arrestin-like, N-terminal, 450010006$IPR011022:Arrestin-like, C-terminal]
arrestin domain containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
arrestin domain containing 2,UP_SEQ_FEATURE[850006154$chain:Arrestin domain-containing protein 2, 850117295$sequence variant, 850118574$splice variant]
ataxin 10,INTERPRO[450017402$IPR019156:Ataxin-10 domain]
ataxin 10,OMIM_DISEASE[520004631$Spinocerebellar ataxia-10]
ataxin 10,PIR_SUPERFAMILY[630021771$PIRSF028927:PIRSF028927]
ataxin 10,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001015$neurodegeneration, 790001431$spinocerebellar ataxia]
ataxin 10,UP_SEQ_FEATURE[850006397$chain:Ataxin-10]
biphenyl hydrolase-like (serine hydrolase),INTERPRO[450000062$IPR000073:Alpha/beta hydrolase fold-1]
biphenyl hydrolase-like (serine hydrolase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000241$carboxylic ester hydrolase, 790000356$complete proteome, 790000445$direct protein sequencing, 790000743$hydrolase, 790001405$signal]
biphenyl hydrolase-like (serine hydrolase),UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850000090$active site:Nucleophile, 850100017$chain:Valacyclovir hydrolase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117814$signal peptide, 850117835$site:Binding of alpha-amino group of substrate, 850118574$splice variant, 850118575$strand, 850118624$turn]
bystin-like,INTERPRO[450007300$IPR007955:Bystin]
bystin-like,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001331$ribosome biogenesis]
bystin-like,UP_SEQ_FEATURE[850008572$chain:Bystin, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
caspase recruitment domain family, member 8,INTERPRO[450001158$IPR001315:Caspase Recruitment, 450010009$IPR011029:DEATH-like]
caspase recruitment domain family, member 8,KEGG_PATHWAY[470038863$hsa04621:NOD-like receptor signaling pathway]
caspase recruitment domain family, member 8,SMART[760000101$SM00114:CARD]
caspase recruitment domain family, member 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001212$polymorphism]
caspase recruitment domain family, member 8,UP_SEQ_FEATURE[850009811$chain:Caspase recruitment domain-containing protein 8, 850103287$domain:CARD, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 17 open reading frame 61,INTERPRO[450006106$IPR006696:Protein of unknown function DUF423]
chromosome 17 open reading frame 61,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
chromosome 17 open reading frame 61,UP_SEQ_FEATURE[850097076$chain:UPF0451 protein C17orf61, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 19 open reading frame 42,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
chromosome 19 open reading frame 42,UP_SEQ_FEATURE[850097937$chain:UPF0608 protein C19orf42, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 8 open reading frame 39,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 8 open reading frame 39,UP_SEQ_FEATURE[850055322$chain:Putative uncharacterized protein C8orf39]
chromosome 9 open reading frame 102,COG_ONTOLOGY[90000121$Transcription / DNA replication, recombination, and repair]
chromosome 9 open reading frame 102,INTERPRO[450000283$IPR000330:SNF2-related, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450002185$IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
chromosome 9 open reading frame 102,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
chromosome 9 open reading frame 102,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000466$dna-binding, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001212$polymorphism]
chromosome 9 open reading frame 102,UP_SEQ_FEATURE[850050572$chain:Putative DNA repair and recombination protein RAD26-like, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850117387$short sequence motif:DEAH box, 850118574$splice variant]
coiled-coil domain containing 43,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein]
coiled-coil domain containing 43,UP_SEQ_FEATURE[850012015$chain:Coiled-coil domain-containing protein 43, 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850106258$modified residue]
cyclin-dependent kinase 6,BBID[10000052$26.cyclin-CDK_complexes, 10000064$4.cyclins_&_p27_cell_cycle, 10000092$71.Id_proteins_G0-to-S_cell_cycle, 10000105$83.Growth_factors_Survival_factors_Mitogens, 10000115$94.E2F_transcriptional_activity_cell_cycle]
cyclin-dependent kinase 6,BIOCARTA[30000059$h_cellcyclePathway:Cyclins and Cell Cycle Regulation, 30000090$h_EfpPathway:Estrogen-responsive protein Efp controls cell cycle and breast tumors growth, 30000119$h_g1Pathway:Cell Cycle: G1/S Check Point , 30000248$h_RacCycDPathway:Influence of Ras and Rho proteins on G1 to S Transition]
cyclin-dependent kinase 6,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
cyclin-dependent kinase 6,KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038836$hsa04115:p53 signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038902$hsa05212:Pancreatic cancer, 470038904$hsa05214:Glioma, 470038908$hsa05218:Melanoma, 470038910$hsa05220:Chronic myeloid leukemia, 470038912$hsa05222:Small cell lung cancer, 470038913$hsa05223:Non-small cell lung cancer]
cyclin-dependent kinase 6,OMIM_DISEASE[520001130$Common variants at CD40 and other loci confer risk of rheumatoid arthritis, 520001993$Genome-wide association analysis identifies 20 loci that influence adult height, 520002597$Identification of ten loci associated with height highlights new biological pathways in human growth, 520003072$Many sequence variants affecting diversity of adult human height, 520004678$Stature QTL 11]
cyclin-dependent kinase 6,PIR_SUPERFAMILY[630000671$PIRSF000564:kinase-related transforming protein]
cyclin-dependent kinase 6,SMART[760000193$SM00220:S_TKc]
cyclin-dependent kinase 6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000134$ATP, 790000138$atp-binding, 790000258$cell cycle, 790000259$cell cycle control, 790000260$cell division, 790000356$complete proteome, 790000389$cyclin, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase]
cyclin-dependent kinase 6,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850010447$chain:Cell division protein kinase 6, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118575$strand, 850118624$turn]
dephospho-CoA kinase domain containing,COG_ONTOLOGY[90000046$Coenzyme metabolism]
dephospho-CoA kinase domain containing,INTERPRO[450001751$IPR001977:Dephospho-CoA kinase]
dephospho-CoA kinase domain containing,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790001063$nucleotide-binding, 790001212$polymorphism]
dephospho-CoA kinase domain containing,UP_SEQ_FEATURE[850014897$chain:Dephospho-CoA kinase domain-containing protein, 850103544$domain:DPCK, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
elastin,INTERPRO[450003502$IPR003979:Tropoelastin, 450003554$IPR004036:Endonuclease III, conserved site-2]
elastin,OMIM_DISEASE[520001287$Cutis laxa, AD, 520004723$Supravalvar aortic stenosis, 520005093$Williams-Beuren syndrome]
elastin,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000530$extracellular matrix, 790000745$hydroxylation, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001640$williams-beuren syndrome]
elastin,UP_SEQ_FEATURE[850017031$chain:Elastin, 850102378$compositionally biased region:Ala-rich, 850102565$compositionally biased region:Poly-Ala, 850102883$disulfide bond, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
family with sequence similarity 180, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
family with sequence similarity 180, member A,UP_SEQ_FEATURE[850045912$chain:Protein FAM180A, 850117295$sequence variant, 850117814$signal peptide]
gem (nuclear organelle) associated protein 7,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001433$Spliceosome]
gem (nuclear organelle) associated protein 7,UP_SEQ_FEATURE[850020866$chain:Gem-associated protein 7, 850105852$helix, 850118575$strand]
glial fibrillary acidic protein,BIOCARTA[30000239$h_prionPathway:Prion Pathway]
glial fibrillary acidic protein,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450006225$IPR006821:Intermediate filament, DNA-binding region, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
glial fibrillary acidic protein,OMIM_DISEASE[520000214$Alexander disease]
glial fibrillary acidic protein,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
glial fibrillary acidic protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000788$Intermediate filament, 790001162$phosphoprotein, 790001212$polymorphism]
glial fibrillary acidic protein,UP_SEQ_FEATURE[850021232$chain:Glial fibrillary acidic protein, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111277$region of interest:Coil 2A, 850111278$region of interest:Coil 2B, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850113286$region of interest:Linker 2, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
glutaminyl-peptide cyclotransferase,INTERPRO[450006838$IPR007484:Peptidase M28]
glutaminyl-peptide cyclotransferase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000025$Acyltransferase, 790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000937$metal-binding, 790001212$polymorphism, 790001405$signal, 790001547$transferase, 790001648$zinc]
glutaminyl-peptide cyclotransferase,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850021671$chain:Glutaminyl-peptide cyclotransferase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106259$mutagenesis site, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118624$turn]
glutathione reductase,BIOCARTA[30000117$h_freePathway:Free Radical Induced Apoptosis]
glutathione reductase,INTERPRO[450000708$IPR000815:Mercuric reductase, 450001169$IPR001327:Pyridine nucleotide-disulphide oxidoreductase, NAD-binding region, 450003614$IPR004099:Pyridine nucleotide-disulphide oxidoreductase, dimerisation, 450005747$IPR006322:Glutathione reductase, animal and bacterial, 450011674$IPR012999:Pyridine nucleotide-disulphide oxidoreductase, class I, active site, 450011694$IPR013027:FAD-dependent pyridine nucleotide-disulphide oxidoreductase]
glutathione reductase,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism]
glutathione reductase,OMIM_DISEASE[520002265$Hemolytic anemia due to glutathione reductase deficiency]
glutathione reductase,PIR_SUPERFAMILY[630000254$PIRSF000210:dihydrolipoamide dehydrogenase]
glutathione reductase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000050$alternative initiation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000537$FAD, 790000559$Flavoprotein, 790000701$homodimer, 790000969$mitochondrion, 790001008$nadp, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism, 790001302$Redox-active center, 790001303$redox-active disulfide, 790001550$transit peptide]
glutathione reductase,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850021757$chain:Glutathione reductase, mitochondrial, 850102883$disulfide bond, 850105852$helix, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
inner membrane protein, mitochondrial (mitofilin),INTERPRO[450017379$IPR019133:Mitochondrial inner membrane protein Mitofilin]
inner membrane protein, mitochondrial (mitofilin),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001212$polymorphism, 790001555$transmembrane]
inner membrane protein, mitochondrial (mitofilin),UP_SEQ_FEATURE[850031975$chain:Mitochondrial inner membrane protein, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118594$topological domain:Mitochondrial intermembrane, 850118596$topological domain:Mitochondrial matrix, 850118623$transmembrane region]
interleukin enhancer binding factor 3, 90kDa,INTERPRO[450001016$IPR001159:Double-stranded RNA binding, 450005981$IPR006561:DZF]
interleukin enhancer binding factor 3, 90kDa,SMART[760000326$SM00358:DSRM, 760000509$SM00572:DZF]
interleukin enhancer binding factor 3, 90kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000466$dna-binding, 790000953$methylation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation]
interleukin enhancer binding factor 3, 90kDa,UP_SEQ_FEATURE[850026487$chain:Interleukin enhancer-binding factor 3, 850102424$compositionally biased region:Arg/Gly-rich, 850102573$compositionally biased region:Poly-Gly, 850102577$compositionally biased region:Poly-Lys, 850102580$compositionally biased region:Poly-Pro, 850103546$domain:DRBM 1, 850103547$domain:DRBM 2, 850103567$domain:DZF, 850106258$modified residue, 850112712$region of interest:Interaction with PRMT1, 850117294$sequence conflict, 850117295$sequence variant, 850117325$short sequence motif:Bipartite nuclear localization signal, 850118574$splice variant]
iroquois homeobox 5,INTERPRO[450001200$IPR001356:Homeobox, 450003418$IPR003893:Iroquois-class homeodomain protein, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
iroquois homeobox 5,SMART[760000341$SM00389:HOX, 760000488$SM00548:IRO]
iroquois homeobox 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001377$sensory transduction, 790001622$vision, 790001628$vitamin d]
iroquois homeobox 5,UP_SEQ_FEATURE[850026829$chain:Iroquois-class homeodomain protein irx-5, 850102565$compositionally biased region:Poly-Ala, 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850102935$DNA-binding region:Homeobox; TALE-type, 850117294$sequence conflict]
kinesin heavy chain member 2A,BBID[10000054$28.KLFs_cytoplas_dynein_cargo_nerve_axons, 10000056$30.Kinesin_superfamily_proteins]
kinesin heavy chain member 2A,INTERPRO[450001552$IPR001752:Kinesin, motor region, 450018052$IPR019821:Kinesin, motor region, conserved site]
kinesin heavy chain member 2A,PIR_SUPERFAMILY[630002446$PIRSF002323:kinesin-related protein KIF2]
kinesin heavy chain member 2A,SMART[760000111$SM00129:KISc]
kinesin heavy chain member 2A,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000428$developmental protein, 790000434$differentiation, 790000960$microtubule, 790000986$motor protein, 790001016$neurogenesis, 790001063$nucleotide-binding, 790001162$phosphoprotein]
kinesin heavy chain member 2A,UP_SEQ_FEATURE[850027491$chain:Kinesin-like protein KIF2A, 850104543$domain:Kinesin-motor, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850111754$region of interest:Globular, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
low density lipoprotein receptor-related protein 5,INTERPRO[450000026$IPR000033:Low-density lipoprotein receptor, YWTD repeat, 450001927$IPR002172:Low density lipoprotein-receptor, class A, cysteine-rich, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450010012$IPR011042:Six-bladed beta-propeller, TolB-like, 450011699$IPR013032:EGF-like region, conserved site, 450015369$IPR017049:Low density lipoprotein receptor-related protein, 5/6, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
low density lipoprotein receptor-related protein 5,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway]
low density lipoprotein receptor-related protein 5,OMIM_DISEASE[520000647$Bone mineral density variability 1, 520000650$Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study, 520001836$Exudative vitreoretinopathy 4, 520002450$Hyperostosis, endosteal, 520003818$Osteopetrosis, AD type I, 520003831$Osteoporosis, 520003837$Osteoporosis-pseudoglioma syndrome, 520003840$Osteosclerosis, 520005010$van Buchem disease, type 2]
low density lipoprotein receptor-related protein 5,PIR_SUPERFAMILY[630027750$PIRSF036314:LDL_recpt-rel_p5/6, 630027751$PIRSF036314:low density lipoprotein receptor-related protein, 5/6 types, 630030929$PIRSF500770:low-density lipoprotein receptor-related protein 5]
low density lipoprotein receptor-related protein 5,SMART[760000117$SM00135:LY, 760000155$SM00181:EGF, 760000166$SM00192:LDLa]
low density lipoprotein receptor-related protein 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000496$Endocytosis, 790000616$glycoprotein, 790000881$lipoprotein, 790000919$membrane, 790001084$osteopetrosis, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001642$wnt signaling pathway]
low density lipoprotein receptor-related protein 5,UP_SEQ_FEATURE[850029132$chain:Low-density lipoprotein receptor-related protein 5, 850102586$compositionally biased region:Pro-rich, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103623$domain:EGF-like 2, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850104665$domain:LDL-receptor class A 1, 850104678$domain:LDL-receptor class A 2, 850104691$domain:LDL-receptor class A 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850116264$repeat:LDL-receptor class B 1, 850116265$repeat:LDL-receptor class B 10, 850116266$repeat:LDL-receptor class B 11, 850116267$repeat:LDL-receptor class B 12, 850116268$repeat:LDL-receptor class B 13, 850116269$repeat:LDL-receptor class B 14, 850116270$repeat:LDL-receptor class B 15, 850116271$repeat:LDL-receptor class B 16, 850116272$repeat:LDL-receptor class B 17, 850116273$repeat:LDL-receptor class B 18, 850116274$repeat:LDL-receptor class B 19, 850116275$repeat:LDL-receptor class B 2, 850116276$repeat:LDL-receptor class B 20, 850116286$repeat:LDL-receptor class B 3, 850116295$repeat:LDL-receptor class B 4, 850116296$repeat:LDL-receptor class B 5, 850116297$repeat:LDL-receptor class B 6, 850116298$repeat:LDL-receptor class B 7, 850116299$repeat:LDL-receptor class B 8, 850116300$repeat:LDL-receptor class B 9, 850117267$repeat:YWTD 1, 850117268$repeat:YWTD 10, 850117269$repeat:YWTD 11, 850117270$repeat:YWTD 2, 850117271$repeat:YWTD 3, 850117272$repeat:YWTD 4, 850117273$repeat:YWTD 5, 850117274$repeat:YWTD 6, 850117275$repeat:YWTD 7, 850117276$repeat:YWTD 8, 850117277$repeat:YWTD 9, 850117294$sequence conflict, 850117295$sequence variant, 850117651$short sequence motif:PPPSP motif, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
matrix metallopeptidase 1 (interstitial collagenase),INTERPRO[450000498$IPR000585:Hemopexin/matrixin, 450001611$IPR001818:Peptidase M10A and M12B, matrixin and adamalysin, 450002196$IPR002477:Peptidoglycan binding-like, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450005466$IPR006026:Peptidase, metallopeptidases, 450014617$IPR016293:Peptidase M10A, matrix metallopeotidase, 450016760$IPR018486:Hemopexin/matrixin, conserved site, 450016761$IPR018487:Hemopexin/matrixin, repeat]
matrix metallopeptidase 1 (interstitial collagenase),KEGG_PATHWAY[470038821$hsa03320:PPAR signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038909$hsa05219:Bladder cancer]
matrix metallopeptidase 1 (interstitial collagenase),OMIM_DISEASE[520001203$COPD, rate of decline of lung function in, 520001708$Epidermolysis bullosa dystrophica, autosomal recessive, modifier of]
matrix metallopeptidase 1 (interstitial collagenase),PIR_SUPERFAMILY[630001331$PIRSF001191:matrix metalloproteinase, stromelysin type, 630001332$PIRSF001191:Peptidase_M10A_matrix]
matrix metallopeptidase 1 (interstitial collagenase),SMART[760000105$SM00120:HX, 760000207$SM00235:ZnMc]
matrix metallopeptidase 1 (interstitial collagenase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000144$autocatalytic cleavage, 790000211$calcium, 790000345$collagen, 790000347$collagen degradation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000530$extracellular matrix, 790000550$fibroblast, 790000616$glycoprotein, 790000733$host-virus interaction, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790000944$metalloproteinase, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001648$zinc, 790001652$zymogen]
matrix metallopeptidase 1 (interstitial collagenase),UP_SEQ_FEATURE[850001196$chain:22 kDa interstitial collagenase, 850001292$chain:27 kDa interstitial collagenase, 850026638$chain:Interstitial collagenase, 850102883$disulfide bond, 850104116$domain:Hemopexin-like 1, 850104117$domain:Hemopexin-like 2, 850104118$domain:Hemopexin-like 3, 850104119$domain:Hemopexin-like 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105910$metal ion-binding site:Calcium 1, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850105925$metal ion-binding site:Calcium 3, 850105927$metal ion-binding site:Calcium 3; via carbonyl oxygen, 850105930$metal ion-binding site:Calcium 4; via carbonyl oxygen, 850106219$metal ion-binding site:Zinc 1, 850106227$metal ion-binding site:Zinc 2; catalytic, 850106228$metal ion-binding site:Zinc 2; in inhibited form, 850109636$propeptide:Activation peptide, 850113432$region of interest:Metalloprotease, 850117294$sequence conflict, 850117295$sequence variant, 850117368$short sequence motif:Cysteine switch, 850117814$signal peptide, 850118006$site:Cleavage; by autolysis, 850118575$strand, 850118624$turn]
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli),INTERPRO[450001859$IPR002099:DNA mismatch repair protein, 450003155$IPR003594:ATP-binding region, ATPase-like, 450010105$IPR011186:DNA mismatch repair protein Mlh1, 450012134$IPR013507:DNA mismatch repair protein, C-terminal, 450013173$IPR014721:Ribosomal protein S5 domain 2-type fold, 450013212$IPR014762:DNA mismatch repair, conserved site, 450013213$IPR014763:DNA mismatch repair protein, N-terminal]
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli),KEGG_PATHWAY[470038824$hsa03430:Mismatch repair, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038903$hsa05213:Endometrial cancer]
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli),OMIM_DISEASE[520000732$Cafe-au-lait spots with glioma or leukemia, 520001096$Colorectal cancer, hereditary nonpolyposis, type 2, 520003334$Mismatch repair cancer syndrome, 520003394$Muir-Torre syndrome, 520004940$Turcot syndrome with glioblastoma]
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli),SMART[760000339$SM00387:HATPase_c]
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli),SP_PIR_KEYWORDS[790000258$cell cycle, 790000356$complete proteome, 790000446$disease mutation, 790000452$DNA damage, 790000459$dna repair, 790000674$hereditary nonpolyposis colorectal cancer, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001580$tumor suppressor]
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli),UP_SEQ_FEATURE[850015585$chain:DNA mismatch repair protein Mlh1, 850106258$modified residue, 850112311$region of interest:Interaction with EXO1, 850117294$sequence conflict, 850117295$sequence variant]
myosin, light chain 5, regulatory,COG_ONTOLOGY[90000111$Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]
myosin, light chain 5, regulatory,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand]
myosin, light chain 5, regulatory,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038857$hsa04530:Tight junction, 470038873$hsa04670:Leukocyte transendothelial migration, 470038881$hsa04810:Regulation of actin cytoskeleton]
myosin, light chain 5, regulatory,SMART[760000046$SM00054:EFh]
myosin, light chain 5, regulatory,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000986$motor protein, 790000997$muscle protein, 790001002$myosin, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
myosin, light chain 5, regulatory,UP_SEQ_FEATURE[850032998$chain:Myosin light chain 5, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
neural precursor cell expressed, developmentally down-regulated 9,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450013377$IPR014928:Serine rich protein interaction]
neural precursor cell expressed, developmentally down-regulated 9,SMART[760000295$SM00326:SH3]
neural precursor cell expressed, developmentally down-regulated 9,SP_PIR_KEYWORDS[790000256$cell adhesion, 790000258$cell cycle, 790000260$cell division, 790000263$cell junction, 790000267$cell projection, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000624$golgi apparatus, 790000635$growth regulation, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
neural precursor cell expressed, developmentally down-regulated 9,UP_SEQ_FEATURE[850017457$chain:Enhancer of filamentation 1, 850017458$chain:Enhancer of filamentation 1 p55, 850105350$domain:SH3, 850106258$modified residue, 850111448$region of interest:Divergent helix-loop-helix motif, 850113083$region of interest:Interacts strongly with spindle- regulatory protein D1M1, 850117295$sequence variant, 850117333$short sequence motif:Caspase cleavage related site]
nuclear pore complex interacting protein,INTERPRO[450000174$IPR000203:GPS, 450000897$IPR001024:Lipoxygenase, LH2, 450008546$IPR009443:Nuclear pore complex interacting]
nuclear pore complex interacting protein,SMART[760000273$SM00303:GPS, 760000278$SM00308:LH2]
nuclear pore complex interacting protein,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790000990$mRNA transport, 790001048$nuclear pore complex, 790001065$nucleus, 790001212$polymorphism, 790001266$protein transport, 790001554$translocation, 790001555$transmembrane, 790001558$transport]
nuclear pore complex interacting protein,UP_SEQ_FEATURE[850035013$chain:Nuclear pore complex-interacting protein, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850117295$sequence variant]
nudix (nucleoside diphosphate linked moiety X)-type motif 22,INTERPRO[450000072$IPR000086:NUDIX hydrolase domain, 450000073$IPR000086:NUDIX hydrolase, core]
nudix (nucleoside diphosphate linked moiety X)-type motif 22,PIR_SUPERFAMILY[630019539$PIRSF025229:Nucleoside diphosphate-linked moiety X motif 22]
nudix (nucleoside diphosphate linked moiety X)-type motif 22,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
nudix (nucleoside diphosphate linked moiety X)-type motif 22,UP_SEQ_FEATURE[850035298$chain:Nucleoside diphosphate-linked moiety X motif 22, 850104864$domain:Nudix hydrolase, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
olfactory receptor, family 2, subfamily AT, member 4,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 2, subfamily AT, member 4,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 2, subfamily AT, member 4,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 2, subfamily AT, member 4,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 2, subfamily AT, member 4,UP_SEQ_FEATURE[850035664$chain:Olfactory receptor 2AT4, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
poliovirus receptor-related 2 (herpesvirus entry mediator B),INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450011799$IPR013162:CD80-like, immunoglobulin C2-set, 450012396$IPR013783:Immunoglobulin-like fold]
poliovirus receptor-related 2 (herpesvirus entry mediator B),KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038856$hsa04520:Adherens junction]
poliovirus receptor-related 2 (herpesvirus entry mediator B),OMIM_DISEASE[520000051$A genome-wide association study for late-onset Alzheimer's disease using DNA pooling]
poliovirus receptor-related 2 (herpesvirus entry mediator B),PIR_SUPERFAMILY[630002151$PIRSF002016:poliovirus receptor-related protein]
poliovirus receptor-related 2 (herpesvirus entry mediator B),SMART[760000357$SM00409:IG]
poliovirus receptor-related 2 (herpesvirus entry mediator B),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000733$host-virus interaction, 790000768$Immunoglobulin domain, 790000919$membrane, 790001162$phosphoprotein, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
poliovirus receptor-related 2 (herpesvirus entry mediator B),UP_SEQ_FEATURE[850039669$chain:Poliovirus receptor-related protein 2, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106259$mutagenesis site, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
poly(rC) binding protein 4,INTERPRO[450003602$IPR004087:K Homology, 450003603$IPR004088:K Homology, type 1, 450016411$IPR018111:K Homology, type 1, subgroup]
poly(rC) binding protein 4,PIR_SUPERFAMILY[630012818$PIRSF016046:PIRSF016046]
poly(rC) binding protein 4,SMART[760000291$SM00322:KH]
poly(rC) binding protein 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790001212$polymorphism, 790001304$repeat, 790001325$ribonucleoprotein, 790001339$rna-binding]
poly(rC) binding protein 4,UP_SEQ_FEATURE[850039771$chain:Poly(rC)-binding protein 4, 850104521$domain:KH 1, 850104527$domain:KH 2, 850104528$domain:KH 3, 850117295$sequence variant, 850118574$splice variant]
prostate cancer susceptibility candidate,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism]
prostate cancer susceptibility candidate,UP_SEQ_FEATURE[850061021$chain:Small nuclear protein PRAC, 850117295$sequence variant]
protein phosphatase 1G (formerly 2C), magnesium-dependent, gamma isoform,INTERPRO[450000191$IPR000222:Protein phosphatase 2C,  manganese/magnesium aspartate binding site, 450001711$IPR001932:Protein phosphatase 2C-related, 450012637$IPR014045:Protein phosphatase 2C, N-terminal, 450014091$IPR015655:Protein phosphatase 2C]
protein phosphatase 1G (formerly 2C), magnesium-dependent, gamma isoform,SMART[760000300$SM00331:PP2C_SIG, 760000301$SM00332:PP2Cc]
protein phosphatase 1G (formerly 2C), magnesium-dependent, gamma isoform,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000899$magnesium, 790000906$manganese, 790000937$metal-binding, 790001162$phosphoprotein, 790001261$protein phosphatase]
protein phosphatase 1G (formerly 2C), magnesium-dependent, gamma isoform,UP_SEQ_FEATURE[850047282$chain:Protein phosphatase 1G, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850106174$metal ion-binding site:Manganese 1, 850106176$metal ion-binding site:Manganese 1; via carbonyl oxygen, 850106177$metal ion-binding site:Manganese 2, 850106258$modified residue]
protein tyrosine phosphatase, receptor type, A,BIOCARTA[30000277$h_srcRPTPPathway:Activation of Src by Protein-tyrosine phosphatase alpha]
protein tyrosine phosphatase, receptor type, A,INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450014489$IPR016130:Protein-tyrosine phosphatase, active site, 450014659$IPR016336:Receptor tyrosine-protein phosphatase, alpha/epsilon-type]
protein tyrosine phosphatase, receptor type, A,PIR_SUPERFAMILY[630002143$PIRSF002006:PTPR_alpha_epsilon, 630002144$PIRSF002006:receptor tyrosine-protein phosphatase, alpha/epsilon types, 630030965$PIRSF500808:receptor tyrosine-protein phosphatase alpha]
protein tyrosine phosphatase, receptor type, A,SMART[760000168$SM00194:PTPc]
protein tyrosine phosphatase, receptor type, A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001261$protein phosphatase, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein, 790001587$tyrosine-specific phosphatase]
protein tyrosine phosphatase, receptor type, A,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850056939$chain:Receptor-type tyrosine-protein phosphatase alpha, 850105594$domain:Tyrosine-protein phosphatase 1, 850105595$domain:Tyrosine-protein phosphatase 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
regulator of G-protein signaling 11,INTERPRO[450000294$IPR000342:Regulator of G protein signalling, 450000504$IPR000591:Pleckstrin/G-protein, interacting region, 450010816$IPR011991:Winged helix repressor DNA-binding, 450014319$IPR015898:G-protein, gamma-like subunit]
regulator of G-protein signaling 11,PIR_SUPERFAMILY[630028460$PIRSF036966:regulator of G protein signaling, RGS7 type]
regulator of G-protein signaling 11,SMART[760000041$SM00049:DEP, 760000196$SM00224:GGL, 760000285$SM00315:RGS]
regulator of G-protein signaling 11,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001408$Signal transduction inhibitor]
regulator of G-protein signaling 11,UP_SEQ_FEATURE[850057020$chain:Regulator of G-protein signaling 11, 850103515$domain:DEP, 850104021$domain:G protein gamma, 850105178$domain:RGS, 850106259$mutagenesis site, 850117295$sequence variant, 850118574$splice variant]
ribosomal protein L13a pseudogene 7; ribosomal protein L13a pseudogene 5; ribosomal protein L13a pseudogene 16; ribosomal protein L13a; ribosomal protein L13a pseudogene 18,INTERPRO[450005209$IPR005755:Ribosomal protein L13, eukaryotic/archaeal, 450005269$IPR005822:Ribosomal protein L13]
ribosomal protein L13a pseudogene 7; ribosomal protein L13a pseudogene 5; ribosomal protein L13a pseudogene 16; ribosomal protein L13a; ribosomal protein L13a pseudogene 18,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein L13a pseudogene 7; ribosomal protein L13a pseudogene 5; ribosomal protein L13a pseudogene 16; ribosomal protein L13a; ribosomal protein L13a pseudogene 18,PIR_SUPERFAMILY[630002312$PIRSF002181:ribosomal protein, L13p/L13Aa/L16e/organellar L13 types, 630002313$PIRSF002181:Ribosomal_L13]
ribosomal protein L13a pseudogene 7; ribosomal protein L13a pseudogene 5; ribosomal protein L13a pseudogene 16; ribosomal protein L13a; ribosomal protein L13a pseudogene 18,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790001255$protein biosynthesis, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001330$ribosome]
ribosomal protein L13a pseudogene 7; ribosomal protein L13a pseudogene 5; ribosomal protein L13a pseudogene 16; ribosomal protein L13a; ribosomal protein L13a pseudogene 18,UP_SEQ_FEATURE[850002613$chain:60S ribosomal protein L13a, 850106258$modified residue]
stomatin,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
stomatin,INTERPRO[450000970$IPR001107:Band 7 protein, 450001747$IPR001972:Stomatin, 450016381$IPR018080:Band 7/stomatin-like, conserved site]
stomatin,PIR_SUPERFAMILY[630005581$PIRSF005651:membrane protease subunits, stomatin/prohibitin homologs]
stomatin,SMART[760000216$SM00244:PHB]
stomatin,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000881$lipoprotein, 790000919$membrane, 790000924$membrane protein, 790001100$palmitate, 790001162$phosphoprotein, 790001555$transmembrane]
stomatin,UP_SEQ_FEATURE[850017802$chain:Erythrocyte band 7 integral membrane protein, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850105902$lipid moiety-binding region:S-palmitoyl cysteine; partial, 850106258$modified residue, 850106259$mutagenesis site, 850112477$region of interest:Interaction with LANCL1, 850114313$region of interest:Required for homooligomerization, 850114407$region of interest:Required for lipid raft association, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
stromal antigen 3-like 4,INTERPRO[450012342$IPR013721:STAG]
stromal antigen 3-like 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
stromal antigen 3-like 4,UP_SEQ_FEATURE[850062323$chain:STAG3-like protein 4, 850117295$sequence variant]
trafficking protein particle complex 4,INTERPRO[450006602$IPR007233:Sybindin-like protein]
trafficking protein particle complex 4,PIR_SUPERFAMILY[630013750$PIRSF016974:TRAPP I complex, Bet5/Trs23 subunits, 630030653$PIRSF500432:TRAPP I complex, Trs23/Trappc4 subunit]
trafficking protein particle complex 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000510$er-golgi transport, 790000624$golgi apparatus, 790001212$polymorphism, 790001558$transport]
trafficking protein particle complex 4,UP_SEQ_FEATURE[850064885$chain:Trafficking protein particle complex subunit 4, 850105852$helix, 850117295$sequence variant, 850118575$strand]
tripartite motif-containing 2,COG_ONTOLOGY[90000016$Carbohydrate transport and metabolism, 90000109$Signal transduction mechanisms]
tripartite motif-containing 2,INTERPRO[450000269$IPR000315:Zinc finger, B-box, 450001109$IPR001258:NHL repeat, 450001143$IPR001298:Filamin/ABP280 repeat, 450001628$IPR001841:Zinc finger, RING-type, 450003195$IPR003649:B-box, C-terminal, 450010012$IPR011042:Six-bladed beta-propeller, TolB-like, 450011685$IPR013017:NHL repeat, subgroup, 450012396$IPR013783:Immunoglobulin-like fold, 450016187$IPR017868:Filamin/ABP280 repeat-like, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
tripartite motif-containing 2,PIR_SUPERFAMILY[630028828$PIRSF037280:tripartite motif protein 2]
tripartite motif-containing 2,SMART[760000158$SM00184:RING, 760000304$SM00336:BBOX, 760000445$SM00502:BBC, 760000496$SM00557:IG_FLMN]
tripartite motif-containing 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000937$metal-binding, 790001162$phosphoprotein, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
tripartite motif-containing 2,UP_SEQ_FEATURE[850066635$chain:Tripartite motif-containing protein 2, 850106258$modified residue, 850115954$repeat:Filamin, 850116579$repeat:NHL 1, 850116580$repeat:NHL 2, 850116581$repeat:NHL 3, 850116582$repeat:NHL 4, 850116583$repeat:NHL 5, 850116584$repeat:NHL 6, 850117294$sequence conflict, 850118638$zinc finger region:B box-type, 850118911$zinc finger region:RING-type]
tyrosine kinase, non-receptor, 1,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001096$IPR001245:Tyrosine protein kinase, 450001294$IPR001452:Src homology-3 domain, 450007559$IPR008266:Tyrosine protein kinase, active site, 450014206$IPR015772:Tyrosine kinase, TNK1, 450015769$IPR017441:Protein kinase, ATP binding site]
tyrosine kinase, non-receptor, 1,SMART[760000192$SM00219:TyrKc, 760000295$SM00326:SH3]
tyrosine kinase, non-receptor, 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain, 790001547$transferase, 790001586$tyrosine-protein kinase]
tyrosine kinase, non-receptor, 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850034578$chain:Non-receptor tyrosine-protein kinase TNK1, 850102586$compositionally biased region:Pro-rich, 850105086$domain:Protein kinase, 850105350$domain:SH3, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ubiquinol-cytochrome c reductase complex chaperone,INTERPRO[450006502$IPR007129:Ubiquinol-cytochrome C chaperone]
ubiquinol-cytochrome c reductase complex chaperone,OMIM_DISEASE[520001131$Common variants in the GDF5-UQCC region are associated with variation in human height, 520002597$Identification of ten loci associated with height highlights new biological pathways in human growth, 520003072$Many sequence variants affecting diversity of adult human height, 520004687$Stature quantitative trait locus 14]
ubiquinol-cytochrome c reductase complex chaperone,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790001212$polymorphism]
ubiquinol-cytochrome c reductase complex chaperone,UP_SEQ_FEATURE[850067925$chain:Ubiquinol-cytochrome c reductase complex chaperone CBP3 homolog, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ubiquitin specific peptidase 9, X-linked,INTERPRO[450001239$IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, 450016487$IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site]
ubiquitin specific peptidase 9, X-linked,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000317$Chromosome partition, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000973$mitosis, 790001162$phosphoprotein, 790001252$Protease, 790001509$thiol protease, 790001593$ubl conjugation pathway]
ubiquitin specific peptidase 9, X-linked,UP_SEQ_FEATURE[850044181$chain:Probable ubiquitin carboxyl-terminal hydrolase FAF-X, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
xeroderma pigmentosum, complementation group C,INTERPRO[450004075$IPR004583:DNA repair protein Rad4, 450016331$IPR018026:DNA repair protein Rad4, subgroup, 450016609$IPR018325:DNA repair protein Rad4, transglutaminase-like domain, 450016610$IPR018326:DNA repair protein Rad4, DNA-binding domain 1, 450016611$IPR018327:DNA repair protein Rad4, DNA-binding domain 2, 450016612$IPR018328:DNA repair protein Rad4, DNA-binding domain 3]
xeroderma pigmentosum, complementation group C,KEGG_PATHWAY[470038823$hsa03420:Nucleotide excision repair]
xeroderma pigmentosum, complementation group C,OMIM_DISEASE[520005122$Xeroderma pigmentosum, group C]
xeroderma pigmentosum, complementation group C,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000452$DNA damage, 790000459$dna repair, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001643$xeroderma pigmentosum]
xeroderma pigmentosum, complementation group C,UP_SEQ_FEATURE[850015731$chain:DNA repair protein complementing XP-C cells, 850102434$compositionally biased region:Arg/Lys-rich (basic), 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102508$compositionally biased region:Glu-rich (acidic), 850102555$compositionally biased region:Lys-rich (basic), 850102572$compositionally biased region:Poly-Glu, 850102581$compositionally biased region:Poly-Ser, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal]
zinc finger protein 205,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 205,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 205,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 205,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 205,UP_SEQ_FEATURE[850101491$chain:Zinc finger protein 205, 850104552$domain:KRAB, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8]
zinc finger protein 662,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 662,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 662,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 662,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 662,UP_SEQ_FEATURE[850101834$chain:Zinc finger protein 662, 850104552$domain:KRAB, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8]
zinc finger protein 689,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 689,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 689,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 689,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 689,UP_SEQ_FEATURE[850101857$chain:Zinc finger protein 689, 850104552$domain:KRAB, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118665$zinc finger region:C2H2-type 12; degenerate, 850118686$zinc finger region:C2H2-type 1; degenerate, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger, MYND-type containing 15,INTERPRO[450002557$IPR002893:Zinc finger, MYND-type]
zinc finger, MYND-type containing 15,SP_PIR_KEYWORDS[790000356$complete proteome, 790000937$metal-binding, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
zinc finger, MYND-type containing 15,UP_SEQ_FEATURE[850101424$chain:Zinc finger MYND domain-containing protein 15, 850102507$compositionally biased region:Glu-rich, 850102586$compositionally biased region:Pro-rich, 850117295$sequence variant, 850118853$zinc finger region:MYND-type]
zinc fingers and homeoboxes 1,INTERPRO[450001200$IPR001356:Homeobox, 450006475$IPR007087:Zinc finger, C2H2-type, 450010997$IPR012287:Homeodomain-related, 450014303$IPR015880:Zinc finger, C2H2-like, 450016278$IPR017970:Homeobox, conserved site]
zinc fingers and homeoboxes 1,SMART[760000323$SM00355:ZnF_C2H2, 760000341$SM00389:HOX]
zinc fingers and homeoboxes 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000196$bone, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000699$Homeobox, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
zinc fingers and homeoboxes 1,UP_SEQ_FEATURE[850102140$chain:Zinc fingers and homeoboxes protein 1, 850102928$DNA-binding region:Homeobox 1, 850102929$DNA-binding region:Homeobox 2, 850102930$DNA-binding region:Homeobox 3, 850102931$DNA-binding region:Homeobox 4, 850102932$DNA-binding region:Homeobox 5, 850105852$helix, 850106258$modified residue, 850114286$region of interest:Required for dimerization, 850114365$region of interest:Required for interaction with NFYA, 850114436$region of interest:Required for nuclear localization, 850114466$region of interest:Required for repressor activity, 850117294$sequence conflict, 850118575$strand, 850118624$turn, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2]
